FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 125 filers reported holding FATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $608,334 | -55.7% | 286,950 | -0.6% | 0.00% | – |
| Q2 2023 | $1,374,312 | +109145.8% | 288,721 | +30.9% | 0.00% | – |
| Q1 2023 | $1,258 | -58.1% | 220,577 | -25.9% | 0.00% | -100.0% |
| Q4 2022 | $3,001 | -99.9% | 297,483 | +14.4% | 0.00% | -50.0% |
| Q3 2022 | $5,825,000 | -45.6% | 259,950 | -39.9% | 0.00% | -50.0% |
| Q2 2022 | $10,711,000 | -42.6% | 432,250 | -12.7% | 0.00% | -33.3% |
| Q1 2022 | $18,668,000 | -30.3% | 495,044 | +8.1% | 0.01% | -25.0% |
| Q4 2021 | $26,800,000 | -5.1% | 458,048 | -3.8% | 0.01% | -11.1% |
| Q3 2021 | $28,226,000 | -30.6% | 476,231 | +1.6% | 0.01% | -25.0% |
| Q2 2021 | $40,694,000 | +7.5% | 468,864 | +2.1% | 0.01% | 0.0% |
| Q1 2021 | $37,847,000 | -10.4% | 459,025 | -1.2% | 0.01% | -14.3% |
| Q4 2020 | $42,260,000 | +111.7% | 464,754 | -7.0% | 0.01% | +75.0% |
| Q3 2020 | $19,966,000 | +9.6% | 499,523 | -5.9% | 0.01% | +14.3% |
| Q2 2020 | $18,218,000 | +111.0% | 530,980 | +36.6% | 0.01% | +75.0% |
| Q1 2020 | $8,635,000 | +28.9% | 388,773 | +13.5% | 0.00% | +33.3% |
| Q4 2019 | $6,700,000 | +37.3% | 342,405 | +9.0% | 0.00% | +50.0% |
| Q3 2019 | $4,879,000 | -19.7% | 314,152 | +4.9% | 0.00% | 0.0% |
| Q2 2019 | $6,079,000 | +475.1% | 299,413 | +397.7% | 0.00% | -66.7% |
| Q1 2019 | $1,057,000 | +5.6% | 60,160 | -22.9% | 0.01% | 0.0% |
| Q4 2018 | $1,001,000 | -34.5% | 77,999 | -16.9% | 0.01% | -25.0% |
| Q3 2018 | $1,529,000 | +62.0% | 93,887 | +12.8% | 0.01% | +33.3% |
| Q2 2018 | $944,000 | +78.8% | 83,268 | +54.0% | 0.01% | +100.0% |
| Q1 2018 | $528,000 | – | 54,063 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |